Pharmacokinetic Drug–Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men

BACKGROUND: Gastroprotective agents are recommended for patients receiving low-dose aspirin (LDA) or nonsteroidal anti-inflammatory drugs (NSAIDs). Vonoprazan is a potassium-competitive acid blocker recently approved for the prevention of peptic ulcer recurrence in patients receiving LDA or NSAIDs....

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Yuuichi, Shiino, Madoka, Horii, Sayako, Okamoto, Hiroyuki, Nakamura, Koki, Nishimura, Akira, Sakata, Yukikuni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209422/
https://www.ncbi.nlm.nih.gov/pubmed/27581248
http://dx.doi.org/10.1007/s40261-016-0455-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209422/
https://www.ncbi.nlm.nih.gov/pubmed/27581248
http://dx.doi.org/10.1007/s40261-016-0455-2

Ejemplares similares